Blueprint Medicines Corp (BPMC)
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Address
45 SIDNEY STREET
CAMBRIDGE, MA 02139
Founded
2008
Number of Employees
655
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s) |
- | $26 | - | - | - | - | - | - | - | - | - | $26 |
Average Price | - | $1.05 | - | - | - | - | - | - | - | - | - | $1.05 |
# Shares Purchased | - | 24,227 | - | - | - | - | - | - | - | - | - | 24,227 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | 8,916.0% | - | - | - | - | - | - | - | - | - | 8,916.0% |
S&P 500 Return to Date | - | 174.1% | - | - | - | - | - | - | - | - | - | 174.1% |
Excess Total Return | - | 8,741.9% | - | - | - | - | - | - | - | - | - | 8,741.9% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | 100% | - | - | - | - | - | - | - | - | - | 100% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)